Literature DB >> 3509945

T cell cross-reactivity among viruses of the paramyxoviridae.

B Ziola1, R H Smith.   

Abstract

Blastogenesis and delayed-type hypersensitivity assays were used to examine mouse T cell responses to five viruses representing the three genera of the Paramyxoviridae. Cross-reactive T cell responses were observed in a lympho-proliferative assay for measles, mumps, respiratory syncytial, canine distemper and parainfluenza type 3 virus. Confirmation of T cell cross-reactivity among measles, mumps and respiratory syncytial virus was obtained with a delayed-type hypersensitivity test. These results show that T cell cross-reactivity is common for Paramyxoviridae viruses, even though these viruses show virtually no inter-genus antibody cross-reactivity. The cross-reactivity among respiratory syncytial, measles and mumps virus at the T cell level may have implications for usage of the attenuated measles/mumps/rubella (MMR) vaccine. Respiratory syncytial virus is contacted by many children before they receive the MMR vaccine and T cells induced by respiratory syncytial virus may influence subsequent development of immunity to measles and/or mumps virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509945     DOI: 10.1089/vim.1987.1.111

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  4 in total

1.  Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.

Authors:  Signe Sørup; Christine Stabell Benn; Lone Graff Stensballe; Peter Aaby; Henrik Ravn
Journal:  Vaccine       Date:  2014-11-01       Impact factor: 3.641

2.  Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.

Authors:  Vu An Do; Sofie Biering-Sørensen; Ane Bærent Fisker; Carlito Balé; Stine Møller Rasmussen; Lone Damkjær Christensen; Kristoffer Jarlov Jensen; Cesário Martins; Peter Aaby; Christine Stabell Benn
Journal:  J Infect Dis       Date:  2017-04-15       Impact factor: 5.226

3.  T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.

Authors:  Katherine M Harris; Sarah E Horn; Melanie L Grant; Haili Lang; Gelina Sani; Mariah A Jensen-Wachspress; Vaishnavi V Kankate; Anushree Datar; Christopher A Lazarski; Catherine M Bollard; Michael D Keller
Journal:  Front Immunol       Date:  2020-10-05       Impact factor: 7.561

4.  Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.

Authors:  Lien Anh Ha Do; Naranzul Tsedenbal; Claire von Mollendorf; Tuya Mungun; Darmaa Bardach; Kim Mulholland
Journal:  J Infect Dis       Date:  2021-10-13       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.